- |||||||||| Trial completion: Data Bank for Eosinophilic Disorders (clinicaltrials.gov) - Jan 22, 2013
P=N/A, N=500, Completed, Active, not recruiting --> Completed Recruiting --> Completed
- |||||||||| Erbitux (cetuximab) / Eli Lilly
Enrollment closed, Metastases: Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (clinicaltrials.gov) - Jan 7, 2013 P1/2, N=43, Active, not recruiting, N=18 --> 1 Recruiting --> Active, not recruiting
- |||||||||| New P4 trial: Surgicel (clinicaltrials.gov) - Dec 30, 2012
P4, N=172, Recruiting,
|